KRISTINA REXROAD: Open Payments
NPI 1912263963 · TAYLORVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 41 payments from 15 companies in 2025. Trend: 2023 $140 · 2024 $475 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $199 |
| Amgen Inc. | 6 | $97 |
| Alpha Cognition USA, Inc. | 1 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Viatris Specialty LLC | 3 | $57 |
| Abbott Laboratories | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
Products named: Rybelsus, Zunveyl, Kerendia, Wegovy, YUPELRI, FREESTYLE LIBRE 3, GEMTESA, REPATHA.
Industry payments across IL — which companies pay providers there.
